Copyright
©The Author(s) 2022.
World J Clin Cases. Aug 16, 2022; 10(23): 8186-8195
Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8186
Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8186
Survival group (n = 157) | Death group (n = 50) | P value | |
Age (yr) | 40 (32, 48) | 51(39, 55) | 0.000 |
Gender (male, %) | 130/157, 82.8 | 42/50, 84.0 | 0.844 |
Classification of liver failure (%) | 0.006 | ||
A | 116/157, 73.89 | 29/50, 58.00 | |
B | 92/157, 58.60 | 16/50, 32.00 | |
C | 2/157, 1.27 | 5/50, 10.00 | |
Stage of liver failure (%) | 0.000 | ||
Early | 101/157, 64.33 | 5/50, 10.00 | |
Middle | 42/157, 26.75 | 13/50, 26.00 | |
Late | 14/157, 8.92 | 32/50, 64.00 | |
Complications (%) | |||
Pulmonary infection | 39/157, 24.84 | 24/50, 48.00 | 0.003 |
Hepatic encephalopathy | 10/157, 6.37 | 23/50, 46.00 | 0.000 |
Spontaneous bacterial peritonitis | 10/157, 6.37 | 11/50, 22.00 | 0.005 |
Hepatorenal syndrome | 0/157, 0 | 4/50, 8.00 | 0.003 |
Upper gastrointestinal hemorrhage | 2/157, 1.27 | 6/50, 12.00 | 0.003 |
PLT (109/L) | 128 (102, 154.50) | 103 (87.50, 153) | 0.044 |
ALB (g/dL) | 3.28 ± 0.50 | 3.21 ± 0.53 | 0.381 |
Tbil (mg/dL) | 13.55 (9.59, 19.88) | 17.19 (12.36, 25.65) | 0.011 |
ALT (U/L) | 948.50 (400, 1984.7) | 838.8 (331.40, 1705.78) | 0.626 |
AST (U/L) | 687.90 (273.85, 1258.50) | 721.50 (252.50, 1554.35) | 0.800 |
CHE (U/L) | 4359 (3288, 5429) | 3898 (2786.75, 5029.50) | 0.197 |
Glu (mmol/L) | 4.26 (3.65, 5.23) | 4.64 (3.73, 5.75) | 0.276 |
BUN (mg/dL) | 9.08 (7.21, 12.30) | 10.97 (8.42, 15.16) | 0.014 |
Cr (mg/dL) | 0.73 (0.61, 0.84) | 0.76 (0.62, 0.94) | 0.309 |
Na (mmol/L) | 136.30 (134.30, 138.00) | 135.22 (132.48, 138.33) | 0.172 |
NLR | 2.66 (1.89, 4.05) | 4.00 (2.42, 6.43) | 0.000 |
INR | 1.83 (1.65, 2.13) | 2.23 (1.93, 3.18) | 0.000 |
HBsAg (log10IU/L) | 3.70 (3.31, 3.91) | 3.23 (2.65, 3.74) | 0.001 |
HBeAg positive (%) | 89/157 (56.70) | 16/50 (32.00) | 0.002 |
HBV-DNA (log10IU/L) | 6.34 (5.14, 7.46) | 6.39 (4.87, 7.82) | 0.698 |
AFP (ng/mL) | 63.15 (15.35, 204) | 16.18 (6.79, 48.33) | 0.000 |
GP73 (ng/mL) | 237.92 (208.84, 309.79) | 305.83 (215.32, 366.49) | 0.003 |
- Citation: Ye QX, Huang JF, Xu ZJ, Yan YY, Yan Y, Liu LG. Short-term prognostic factors for hepatitis B virus-related acute-on-chronic liver failure. World J Clin Cases 2022; 10(23): 8186-8195
- URL: https://www.wjgnet.com/2307-8960/full/v10/i23/8186.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i23.8186